UNSPSC 85891830: High dose rate (hdr) brachytherapy of pituitary gland using cesium 137 (cs-137)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of pituitary gland using cesium 137 (cs-137). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DG1097Z

UNSPSC 85891830 High dose rate (HDR) brachytherapy of pituitary gland using cesium 137 (Cs-137) is a Commodity code that shows no recent state and local procurement activity aligned with its nominal scope. The single opportunity posted under this code—Santa Clara County Health System's RFQ for temporary health professional staffing services (RFSQHHSFY270052, due October 7, 2026)—is unrelated to brachytherapy or radiological treatment and instead solicits ancillary clinical staffing across audiology, cardiology, diagnostic imaging, gastroenterology, and thirteen other health professional categories. The mismatch suggests either a data-tagging error in the source or minimal recent state and local activity in specialized cancer-treatment radiation therapy under this specific code designation.

Given the misalignment between the code's technical medical scope and the staffing solicitation posted against it, this code does not present a reliable platform for business development targeting state and local brachytherapy procurement at this time. Vendors in high-dose-rate radiation oncology should monitor state health system RFPs and capital equipment solicitations through direct channels rather than relying on this code's recent posting history.